C18orf8 antibody (Cy5)

Catalog No. ABIN1421892

The Cy5-conjugated Rabbit Polyclonal anti-C18orf8 antibody (ABIN1421892) specifically detects C18orf8 in WB and IF (p). The antibody is reactive with Human samples.

Quick Overview for C18orf8 antibody (Cy5) (ABIN1421892)

Target: C18orf8 (Chromosome 18 Open Reading Frame 8 (C18orf8))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This C18orf8 antibody is conjugated to Cy5

Application: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Product Details anti-C18orf8 Antibody (Cy5)

Cross-Reactivity: Human

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human MIC1/C18orf8

Isotype: IgG

Application Details

Application Notes: IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for C18orf8

Target: C18orf8 (Chromosome 18 Open Reading Frame 8 (C18orf8))

Alternative Name: MIC1

Background:

Synonyms: C18orf8, Chromosome 18 open reading frame 8, Colon cancer associated protein Mic1, Colon cancer-associated protein Mic1, HsT2591, Mic-1, MIC1, MIC1_HUMAN, Uncharacterized protein C18orf8.

Background: MIC1 is a 657 amino acid protein that contains one MIC1 domain and is encoded by a gene which maps to human chromosome 18. Chromosome 18 houses over 300 protein-coding genes and contains nearly 76 million bases. There are a variety of diseases associated with defects in chromosome 18-localized genes, some of which include Trisomy 18 (also known as Edwards syndrome), Niemann-Pick disease, hereditary hemorrhagic telangiectasia, erythropoietic protoporphyria and follicular lymphomas.